Clinical Trials Ver-A-T1D
This known blood pressure lowering drug has been shown recently to protect and strengthen beta cells and slowing down beta cell destruction in T1D.

RECRUITING
A second INNODIA trial now started with Verapamil. This known blood pressure lowering drug has been shown recently to protect and strengthen beta cells and slowing down beta cell destruction in T1D. The trial will include 120 patients aged between 18 and 45 years, taking tablets for 1 year.
In this movie, the trial specific information starts at minute 3.